The effect of Zafirlukast on capsule formation in post-radiation silicone implants

Medical Hypotheses

Volumn 78, Issue 6, 2012, Pages 787-789

  Sapountzis, Stamatis ^a   Kim, Ji Hoon ^b   Francescato Veiga, Daniela ^c   Masako Ferreira, Lydia ^c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b Seoul National University Bundang Hospital   (South Korea)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; HYALURONIC ACID; MATRIX METALLOPROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; ZAFIRLUKAST;

ARTICLE; BREAST AUGMENTATION; CANCER RADIOTHERAPY; CLINICAL FEATURE; DRUG EFFECT; FOREIGN BODY GRANULOMA; GIANT CELL; HUMAN; HYPOTHESIS; IMPLANT CAPSULAR CONTRACTURE; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PROPHYLAXIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIATION DOSE; SILICONE PROSTHESIS;

BINDING, COMPETITIVE; BREAST IMPLANTS; BREAST NEOPLASMS; FEMALE; HUMANS; IMPLANT CAPSULAR CONTRACTURE; LEUKOTRIENE ANTAGONISTS; MASTECTOMY; RADIOTHERAPY; RECEPTORS, LEUKOTRIENE; TOSYL COMPOUNDS;

EID: 84860368034     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.03.007     Document Type: Article

References (34)

1. Sheppard L.A., Ely S. Breast cancer and sexuality. Breast J 2008, 14(2):176-181.
2. Veras-Castillo E.R., Cardenas-Camarena L., Lyra-Gonzalez I., Muñoz-Valle J.F., Lucano-Landeros S., Guerrerosantos J., et al. Controlled clinical trial with pirfenidone in the treatment of breast capsular contracture: association of TGF-β polymorphisms. Ann Plast Surg 2011, http://dx.doi.org/10.1097/SAP.0b013e31822284f4.
3. Miller B.A., Scoppa S.M., Feuer E.J. Racial/ethnic patterns in lifetime and age-conditional risk estimates for selected cancers. Cancer 2006, 106:670-682.
4. American Society of Plastic Surgeons. Report of the 2010 statistics. Available from: . http://www.plasticsurgery.org.
5. Martin Jugenburg, Disa Joseph J., Pusic Andrea L., Cordeiro Peter G. Impact of radiotherapy on breast reconstruction. Clin Plast Surg 2007, 34:29-37.
6. Whitfield G.A., Horan G., Irwin M.S., Malata C.M., Wishart G.C., Wilson C.B. Incidence of severe capsular contracture following implant-based immediate breast reconstruction with or without postoperative chest wall radiotherapy using 40 Gray in 15 fractions. Radiother Oncol 2009, 90(1):141-147.
7. Wyatt Lance E., Sinow J., Wollman J.S., Sami D.A.B.S., Miller T.A. The influence of time on human breast capsule histology: smooth and textured silicone-surfaced implants. Plast Reconstr Surg 1998, 102:1922-1931.
8. Lipa J.E., Qiu W., Huang N., Alman B.A., Pang C.Y. Pathogenesis of radiation-induced capsular contracture in tissue expander and implant breast reconstruction. Plast Reconstr Surg 2010, 125(2):437-445.
9. Kuhn A., Singh S., Smith P.D., Ko F., Falcone R., Lyle W.G., et al. Periprosthetic breast capsules contain the fibrogenic cytokines TGF-beta1 and TGF-beta2, suggesting possible new treatment approaches. Ann Plast Surg 2000, 44(4):387-391.
10. Randall K., Coggle J.E. Expression of transforming growth factor-beta 1 in mouse skin during the acute phase of radiation damage. Int J Radiat Biol 1995, 68:301-309.
11. Randall K., Coggle J.E. Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation. Int J Radiat Biol 1996, 70:351-360.
12. Schultze-Mosgau S., Wehrhan F., Rödel F., Amann K., Radespiel-Tröger M., Grabenbauer G.G. Transforming growth factor-beta receptor-II up-regulation during wound healing in previously irradiated graft beds in vivo. Wound Repair Regen 2003, 11(4):297-305.
13. Li C., Wilson P.B., Levine E., Barber J., Stewart A.L., Kumar S. TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer 1999, 84(2):155-159.
14. Ulrich D., Noah E.M., Burchardt E.R., Atkins D., Pallua N. Serum concentration of amino-terminal propeptide of type III procollagen (PIIINP) as a prognostic marker for skin fibrosis after scar correction in burned patients. Burns 2002, 28(8):766-771.
15. Tao J., Peng H.Q., Cai W.M., Dong F.Q., Weng H.L., Liu R.H. Influence factors of serum fibrosis markers in liver fibrosis. World J Gastroenterol 2003, 9(11):2497-2500.
16. Xie S.B., Yao J.L., Zheng R.Q., Peng X.M., Gao Z.L. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. Hepatobiliary Pancreat Dis Int 2003, 2(1):69-72.
17. Rosenbaum D., Peric S., Holecek M., Ward H.E. Hyaluronan in radiation-induced lung disease in the rat. Radiat Res 1997, 147(5):585-591.
18. Prantl L., Pöppl N., Horvat N., Heine N., Eisenmann-Klein M. Serologic and histologic findings in patients with capsular contracture after breast augmentation with smooth silicone gel implants: is serum hyaluronan a potential predictor?. Aesthet Plast Surg 2005, 29:510-518.
19. Rah M.J. A review of hyaluronan and its ophthalmic applications. Optometry 2011, 82(1):38-43.
20. Little G., Baker J.L. Results of closed compression capsulotomy for treatment of contracted breast implant capsules. Plast Reconstr Surg 1980, 65(1):30-33.
21. Katzel E.B., Koltz P.F., Tierney R., Williams J.P., Awad H.A., O'Keefe R.J., et al. A novel animal model for studying silicone gel-related capsular contracture. Plast Reconstr Surg 2010, 126(5):1483-1491.
22. Komorowska-Timek E., Oberg K.C., Timek T.A., Gridley D.S., Miles D.A. The effect of AlloDerm envelopes on periprosthetic capsule formation with and without radiation. Plast Reconstr Surg 2009, 123(3):807-816.
23. Eltze E., Schäfer U., Bettendorf O., Rody A., Herchenröder F., Chiwritsch T., et al. Radiation-induced capsule tissue reactions around textured breast implants in a rat model. Breast 2006, 15(3):331-338.
24. Adams W.P., Haydon M.S., Raniere J., Trott S., Marques M., Feliciano M., et al. A rabbit model for capsular contracture: development and clinical implications. Plast Reconstr Surg 2006, 117(4):1214-1219. [discussion 1220-1].
25. Scuderi N., Mazzocchi M., Fioramonti P., Bistoni G. The effects of zafirlukast on capsular contracture: preliminary report. Aesthet Plast Surg 2006, 30(5):513-520.
26. Riccioni G., Bucciarelli T., Mancini B., Di Ilio C., D'Orazio N. Antileukotriene drugs: clinical application, effectiveness and safety. Curr Med Chem 2007, 14(18):1966-1977.
27. Perng D.W., Wu Y.C., Chang K.T., Wu M.T., Chiou Y.C., Su K.C., et al. Leukotriene C4 induces TGF-beta1 production in airway epithelium via p38 kinase pathway. Am J Respir Cell Mol Biol 2006, 34(1):101-107. [Epub 2005 Sep 22].
28. Shimbori C., Shiota N., Okunishi H. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Eur J Pharmacol 2011, 650(1):424-430. [Epub 2010 Oct 27].
29. Asakura T., Ishii Y., Chibana K., Fukuda T. Leukotriene D4 stimulates collagen production from myofibroblasts transformed by TGF-beta. J Allergy Clin Immunol 2004, 114(2):310-315.
30. El-Swefy S., Hassanen S.I. Improvement of hepatic fibrosis by leukotriene inhibition in cholestatic rats. Ann Hepatol 2009, 8(1):41-49.
31. Grella E., Grella R., Siniscalco D., Fuccio C., Rossi F., De Novellis V., et al. Modification of cysteinyl leukotriene receptors expression in capsular contracture: follow-up study and definitive results. Ann Plast Surg 2009, 63(2):206-208.
32. Schlesinger S.L., Ellenbogen R., Desvigne M.N., Svehlak S., Heck R. Zafirlukast (Accolate): a new treatment for capsular contracture. Aesthet Surg J 2002, 22(4):329-336.
33. Bastos E.M., Neto M.S., Alves M.T., Garcia E.B., Santos R.A., Heink T., et al. Histologic analysis of zafirlukast's effect on capsule formation around silicone implants. Aesthet Plast Surg 2007, 31(5):559-565.
34. Moreira M., Fagundes D.J., de Jesus Simões M., de Oliveira M.C., Dos Santos Previdelli I.T., Moreira A.C. Zafirlukast pocket delivery impairs the capsule healing around textured implants in rats. Aesthet Plast Surg 2009, 33(1):90-97.